I t has been known for over 70 years that workers exposed to various chemical substances, such as coal tars, chromium compounds, and aromatic amines, have an increased incidence of skin, urinary tract, and lung cancers (Rogers, 1987) . The result of exposure to these chemicals may be DNA damage, interfering with DNA replication, and leading to possible neoplastic or chromosomal mutations and the development of cancer.
Many drugs in use today are known or suspected of causing cancer in humans (Hoar, 1981; Hoover, 1981) . A number of the anticancer drugs in use today have proven carcinogenic and mutagenic in bacteria or animal studies (Rubadue, 1985) . Manyantineoplastic drugs are potent, toxic substances causing direct irritant effects on exposed skin, mucous membranes, eyes, and other tissues (D'Arcy, 1983; Hunt, 1984; Rogers, 1986; Rubadue, 1985; Selvey, 1985) . Knowles (1980) listed 21 commonly used cytotoxic drugs, 16 of which are known to cause skin irritation. Many persons being treated with cytotoxic drugs are at increased risk for developing a second malignancy (Caldwell, 1977; Harris, 1976; Harrison, 1981) .
Cytotoxic drugs are designed to With the increased use and development of toxic and potent drugs, the exposure of health care workers, especially nurses and pharmacists, to the hazards of these agents has increased.
cause cell death by interacting with cellular DNA, RNA, or protein synthesis. The side effects caused by these drugs are due to their inability to differentiate between neoplastic and healthy cells (Zimmerman, 1981) . Due to their action on DNA, RNA, and protein synthesis, many of these drugs are recognized as mutagenic, carcinogenic, and teratogenic (D'Arcy, 1983; Rogers, 1987; Zimmerman, 1981) . Evidence in support of their carcinogenicity states that many persons treated with antineoplastic drugs do develop a second malignancy due to treatment with these agents (Hoover, 1981; Pape, 1988; Rogers, 1987; Rubadue, 1985; Sorsa, 1985; Zimmerman, 1981) .
Since many health care professionals, including nurses, may come in contact with these agents during preparation, administration, and disposal, they may also share exposure risks with the clients receiving these drugs. The most common routes of exposure of health care workers are through skin absorption and inhalation (Rubadue, 1985; Valanis, 1985) .
Abundant literature substantiates the effectiveness of protective practices and equipment (Anderson, 1982; Rogers, 1987; Rubadue, 1985) . These studies used tests for urinary mutagenicity to demonstrate the effectiveness of self protective practices. Protective equipment includes masks, gloves, gowns, goggles, and laminar flow hoods. While these techniques have been shown to decrease exposure of personnel to these agents, many health care workers do not use these protective methods consistently (Brookshire, 1987; Rogers, 1987; Tortorici, 1980) . Antineoplastic drugs are given to an estimated 200,000 to 400,000 persons annually (Anderson, 1982; Rubadue, 1985) . With the increased use and development of such toxic and potent drugs, the exposure of health care workers, especially nurses and pharmacists, to the hazards of these agents has increased. With the advent of more sophisticated diagnostic methods, numerous cancers are being detected at earlier and more treatable stages, which often means intensive therapy with cytotoxic drugs.
Nurses may be exposed to antineoplastic drugs during mixing, administration, and disposal. Primary routes of exposure to these drugs are inhalation of the aerosolized forms of the drug, direct skin contact, and at times ingestion (Rogers, 1986; Valanis, 1985; Zimmerman, 1981) . Excreta from persons receiving certain cytotoxic drugs contain high levels of the drug or its potentially dangerous metabolites, providing yet another source of contact (Stolar, 1984; Venitt, 1984; Zimmerman, 1981) .
To fully assess the use of protection by individuals, it must also be established whether there are policies for handling these drugs, and whether or not protective equipment and work areas are provided. This study, a replication of work completed in Cincinnati, Ohio, (Valanis, B., unpublished data, 1987) was designed to answer these questions.
METHODS
Questionnaires were mailed to all hospitals, hospices, home care agencies, and oncologist offices in an eight county area of West Tennessee. In addition, a random sample of 10% of the remaining physician offices were also included in the sample. The questionnaire, used with permission, was designed to determine who prepares and administers chemotherapeutic agents; where these drugs are being mixed and administered; what protective equipment and procedures are available, and if they are used; and whether the facility has a formal, written policy concerning the safe handling of these drugs. Face and content validity of the instrument were established by Valanis (unpublished data, 1987) , and interrater reliability was ascertained by comparing the consistency of responses ofvarious administrators from a single institution who participated in a pilot study. This survey dramatically demonstrates the lack of standardization of written procedures and guidelines, as well as great inconsistencies in actual practice.
Each facility administrator surveyed was asked to complete the mailed questionnaire and to forward a copy of the facility's policy concerning the handling of cytotoxic drugs. If a reply was not received within 2 weeks, a postcard was mailed asking if the facility did or did not handle cytotoxic drugs and whether or not the administrator wished to participate in the study. If the response was affirmative to participation, a second questionnaire was mailed.
A second questionnaire and cover letter were also sent to all hospitals that did not reply to the first mailing, as these institutions had a high probability of handling cytotoxic drugs. Two weeks were allowed for all incoming data to be received. An additional 2 weeks were allowed to obtain follow up information from nonrespondents.
Copies of the returned written policies (n =5) concerning the handling of antineoplastic drugs were mailed to content experts in Cincinnati for analysis and evaluated using an instrument developed by Valanis (unpublished data, 1987) . The coding instrument compared each policy with current Occupational Safety and Health Administration (OSHA, 1986) work practice guidelines. These guidelines describe the equipment and practices necessary to carry out these procedures safely, and serve to limit the exposure of workers to cytotoxic drugs. Content areas assessed were: general guidelines; equipment; facilities; apparel; and protec-tive techniques. Reliability and validity of the content analysis were demonstrated in the original study (Valanis, unpublished data, 1987) . Analysis of the policies for this study was completed using procedures developed in the original study by coders who had been trained for the original study.
RESULTS
A total of 261 questionnaires were mailed, with a response rate of 56%. The breakdown of facilities that received and returned questionnaires or postcards is shown in Table 1 . Of the 146 respondents, only 24 reported handling antineoplastic drugs. While the survey included 23 oncologists, fewer than half responded and only six of those reported using cytotoxic drugs. Of the six randomly selected physicians that reported use of cytotoxic drugs, half of these were urologists. All 24 agencies that reported handling these agents administered the drugs, but only 20 agencies (83%) mixed the drugs.
Pharmacists were most likely to be engaged in preparing the drugs, while nurses were most often reported to administer the agents, followed by physicians. Two thirds of the respondents reported having policies regarding preparation of these agents and three quarters of the agencies reported having policies regarding the administration of the drugs (Table  2) . Disposal policies for used drugs and equipment were reported by 75% of the respondents who handled these drugs.
Protective Measures
Gloves were worn by a large percentage of respondents for both mixing and administering cytotoxic drugs, but all other methods of self protection, such gowns, masks, and lab coats, showed variable use (Table  3) . Masks were worn more frequently when mixing the drugs than when administering them, but the overall use of this self protective method was low. Of the 20 facilities that mixed antineoplastic agents, 10 reported that preparation was ac- of OSHA guidelines. One hospital offered any pregnant or breast feeding employee the right to move to work areas where antineoplastic drugs would not be encountered. This policy also applied to those employees trying to conceive. That same hospital also mandated the use of latex gloves by personnel who carne into contact with the blood of patients taking cytotoxic drugs for up to 48 hours after the last dose. OSHA recommends this procedure
TABLE 1
Respondents to Questionnaire complished in the pharmacy,S used special medicine rooms, 3 used specially designated areas on the unit, and 2 used the regular medicine room. Slightly more than half of the persons mixing cytotoxic drugs used laminar flow hoods.
The majority of facilities reported disposing of unused drugs and equipment in a prescribed manner (Table  4) . A large number of the respondents were concerned about the various effects that may be associated with the use of cytotoxic drugs. Fourteen respondents were concerned about local effects on the skin from spillage; 11 were aware of potential acute systemic effects from absorption of the drug during mixing and administration; and 18 listed chronic systemic effects from drug absorption as a concern. One respondent listed legal concerns, but did not elaborate on what this meant specifically.
Policy Analysis
Although 16 respondents reported having policies concerning the proper method for handling cytotoxic drugs, only five agencies returned a copy of their policy as requested. All five of the respondents who returned written policies were urban hospitals. Some of the policies were concerned only with the handling of antineoplastic drugs in the pharmacy. The highest possible total score according to the coding instrument was 215, which would indicate the most comprehensive policy. The five scores obtained from the policies returned in the survey were 58, 34, 20, 11, and 11. Table 5 shows the highest possible scores for each of the content categories as well as the range of scores for the policies analyzed.
All facilities except one addressed hand washing, and two facilities had policies concerning transportation of drugs and used equipment throughout the hospital. Three hospitals named procedures to be followed in the event of a spill, and one hospital addressed the handling of contaminated linens. All five hospitals had policies for preparing antineoplastic drugs, but only two had specific policies for the administration of these agents. This might be due to the fact that some policies dealt only with the pharmacy and did not address other personnel involved with these drugs. All respondents had written procedures for the disposal of cytotoxic drugs.
Overall, policies were found to be inconsistent among institutions and very narrow in scope. However, in a few isolated instances, requirements in the written policies exceeded those 
DISCUSSION
This survey dramatically demonstrates the lack of standardization of written procedures and guidelines, as well as great inconsistencies in actual practice. Brookshire (1987) reported a larger percentage of institutions with written policies and procedures (52%) than did this survey, but they also discovered inconsistencies in hospitals' methods of evaluating employee compliance. Even with the small sample of returned policies, great variances in what the written policies require and the specific areas to which they apply are apparent. All policies were very narrow in scope, even in the limited areas that each one addressed. This was evidenced bv the low scores obtained by each policy in every area of the content analysis.
The lack of written policies regarding the handling of cytotoxic drugs reported by some institutions may indicate a lack of knowledge of the potential dangers of such drugs. However, with the increasing concern and public awareness regarding this issue, this seems unlikely.
A more plausible reason for the lack of written policies may be the financial crisis that has currently enveloped the health care system nationwide. The added costs inherent in such measures could foster resistance to adopting strict, mandatory written policies and procedures. These costs include not only the monetary outlay for the purchase of equipment and supplies, but also the costs associated with the education and training of personnel. Although it is imperative in today's health care setting that costs be contained, the authors believe the cost is inconsequential when compared to the health and safety of all employees.
Inconsistency in relating the concerns of some respondents for possi-6 2 15 Vials, Syringes, and IV Tubing 2 5 6 2 12 Drugs ties may have been overlooked. Another limitation is that the questionnaire was sent to each facility's administrator, who might not have been the person with the most information concerning the use and handling of cytotoxic drugs. Since some questionnaires were answered by pharmacists and addressed only the pharmacy's handling of these agents, the question of whether or not there were policies addressing the handling of cytotoxic drugs in other departments within the institution was left unanswered. The unwillingness of facilities to answer the questionnaire voluntarily was a drawback that was addressed by contacting non-respondents. It is also recognized that the nature of the for only 24 hours. Another hospital required that in the event of eye contamination, the eyes should be flooded with water for 15 minutes, although OSHA guidelines specify flushing the eyes for only 5 minutes.
LIMITATIONS OF THE STUDY
The value of this survey is limited by the small sample size, particularly in regard to the small number of policies available for the policy review. This makes generalization of the findings to larger populations difficult. The fact that the returned policies were very inconsistent and narrow in scope also limits the generalizability of the results.
Since this study involved a nonrandom sample, some eligible facili-1981; OSHA, 1986; Stolar, 1984; Zimmerman, 1981) , which are necessary to ensure workers' safety. However, establishment of written policies and procedures mandates some method of follow up to ascertain employee compliance. Brookshire (1987) noted that several hospitals that reported having established policies for handling these drugs also reported no mechanism for evaluating employee compliance to written policies and procedures.
The occupational health nurse needs to know how to design and conduct research studies. Data about physical consequences of exposure to cytotoxic drugs, information is also crucial in reference to employees' adherence to policies, and actual use of mandated self protection are all needed for evaluation. Appropriate documentation, recordkeeping, and follow up are necessary components for quality assurance, as well as to provide for analytical or descriptive studies.
The need for further research is apparent in several areas. The ever increasing widespread use of toxic drugs mandates studies to delineate the precise short and long term effects of exposure of both clients and health care personnel. Confirmative human studies are crucial in determining whether exposure to these drugs does indeed lead to specific physiologic alterations. Numerous factors must be analyzed and assessed ble effects of exposure to these drugs to the actual policies, procedures, and practices used to prevent unnecessary exposure of personnel was found. The lack of consistent use of self protective measures by personnel is troubling in light of the seemingly abundant literature on the dangers of cytotoxic drugs. While there are no specific data on the exact health risks workers face when exposed to these drugs in the workplace, there is mounting evidence that exposure does result at times in measurable, definitive consequences (Anderson, 1982; Caudell, 1988; Falck, 1979; Harrison, 1981; Hirst, 1984; Rogers, 1986; Sorsa, 1985; Stolar, 1984; Venitt, 1984; Waksvik, 1981) .
Unfortunately, this study did not assess the reasons for the irregular and inconsistent use of self protective measures. It is impossible to know if these measures were not used because of a lack of knowledge on the part of personnel (either of the risks involved regarding exposure to cytotoxic drugs or of when and how to use protective equipment) or a lack of availability of protective equipment.
In addition to supplying gowns, masks, gloves, flow hoods, and special work areas, the facility must make these items readily available and accessible to all health care personnel who might need them. The authors realize that even in the face of mounting data and the known toxicity of these drugs, some workers will disregard the possibility that they may fall prey to the consequences of unnecessary exposure to these agents. Some personnel will inevitably fail to protect themselves, even with proper training, equipment, and procedures. However, some may be more motivated to protect themselves in the face of an established and consistent institutional policy.
RECOMMENDATIONS
For such policies and procedures to be effective, they must be accompanied by inservice education designed to teach personnel the risks involved with the handling of these drugs, the different routes of exposure, and the means to protect both themselves and others from unnecessary exposure. This is a vital role for the occupational health nurse and a critical area for intervention, particularly in large medical centers where large amounts of cytotoxic drugs are administered. To decrease the risk of unnecessary exposure of health care personnel to cytotoxic drugs, the occupational health nurse needs to meet several objectives.
The first objective is to makeadministrators aware of the potential dangers of exposure to these drugs. This is the first step in obtaining their commitment to ensuring worker safety, a necessary component of any institutional policy or procedure.
Occupational health nurses are necessary members of groups delegated to either update existing policies or draft new ones. Their training enables them to integrate the requirements of all departments (from housekeeping, to physical therapy, to the pharmacy, etc.) in one comprehensive, reasonable policy or procedure. Their knowledge of nursing procedures, pharmacology, and principles of teaching and learning provides a comprehensive overview of a problem that is easily fragmented into different areas of concern.
Numerous authors have already provided guidelines on the safe handling of cytotoxic drugs (Harrison, 
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There is increasing evidence that exposure to antineoplas-• tic drugs in the workplace has definite, measurable effects on health care workers. The literature supports the theory that use of proper protective practices and equipment while handling antineoplastic drugs will provide adequate protection from the effects of these agents.
Research is imperative to determine the exact long term effects of exposure to antineoplastic drugs by health care workers and to develop ways to ensure proper, consistent use of safety measures.
of this type should sample all urologists as well as all oncologists.
CONCLUSION
Clearly, much work remains to be done in defining the scope and extent of this situation. Even though there is presently little definitive data concerning the exact health risks of personnel due to long term low dose exposure to cytotoxic drugs (Bartkowski-Dodds, 1983) , reasonable, comprehensive policies and procedures are still clearly mandated and justified. Such measures are consistent with the recommendations in the literature (Bankowski-Dodds, 1983; Harrison, 1981; Knowles, 1980; Mattia, 1983; Rogers, 1986; Stolar, 1984; Zimmerman, 1981) .
The increasing concern over the possible effects of exposure to these toxic agents should serve to heighten the awareness of all health care providers regarding the safe handling of such potent and dangerous drugs. Nurses are in an ideal position to coordinate and monitor the actions taken to address this critical situation. and possible consequences of unnecessary exposure as well as their actual use of self protective measures (if any). Of course, the necessary first step in dealing with those physician practices would be to obtain the cooperation and assistance of the physicians involved. Future studies The increasing concern over the possible effects of exposure to these toxic agents should serve to heighten the awareness of all health care providers regarding the safe handling of such potent and dangerous drugs.
Many of the hospitals, physicians' offices, and health care agencies surveyed did not have comprehensive policies outlining safe practices and procedures when handling antineoplastic drugs. Use of gloves was the only consistently used method of self protection in any facility that responded to the survey.
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regarding self-care behaviors (or lack of them) of personnel. These factors have a definite impact on education and teaching strategies and therefore must be better understood and accounted for to provide innovative and effective educational sessions. It is noteable that half of the six randomly selected urologists reponed using cytotoxic drugs, although the extent of this use is unknown. Since the handling of cytotoxic drugs is not a primary function of the personnel employed in these practices (as opposed to an oncology practice), more information is needed regarding the actual type of drugs used, the extent of their use, and whether or not there are guidelines regarding the handling of such drugs. If guidelines are in place, it will be necessary to evaluate them for comprehensiveness and effectiveness.
A prerequisite to training these personnel would be evaluation of their present knowledge of the drugs
